YMM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient buyer. The near-term tape is still bearish (SMA_200 > SMA_20 > SMA_5) and options positioning is aggressively defensive (very high put volume vs calls), suggesting downside/volatility risk before any durable rebound. If you already own it, holding makes more sense than chasing a fresh entry today; for a new position, I would avoid buying until price reclaims the pivot (~9.96) and starts holding above ~10.16 resistance.
Price closed at 9.90 (-2.46% vs prior close 10.15), sitting just below the pivot (9.956) and near first support (S1 9.748). Trend structure remains bearish with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), implying rallies are still likely to be sold. However, momentum is trying to stabilize: MACD histogram is positive and expanding (0.0341), which often precedes a short-term bounce. RSI(6) at ~39.98 is weak but not deeply oversold, so there’s room for further downside before a forced mean-reversion. Key levels: support 9.75 then 9.62; resistance 10.16 then 10.29. A convincing buy setup would be a hold above 10.16 with improving breadth/volume; right now it’s still a fragile spot just below the pivot.
Momentum early signs: MACD improving while price is near support could fuel a technical bounce if it regains 10.
Wall Street still sees upside vs spot: recent targets clustered around $12–$14 (even after cuts), well above the 9.90 price.
Q3 revenue growth remained solid (+10.78% YoY), supporting the longer-term business trajectory if profitability normalizes.
Primary trend is still down (bearish MA stack), making entries vulnerable to further drawdowns.
Options market is strongly skewed to puts on volume (P/C 11.24), implying traders are braced for more weakness.
Profitability pressure in the latest quarter: net income (-18.05% YoY), EPS (-20% YoY), and gross margin down (~5.04% YoY) increase the risk of valuation multiple compression.
Analyst commentary highlights decelerating transaction service revenue growth outlook / softer near-term order volume guidance impacts, which can cap rallies.
No recent news catalysts to quickly flip sentiment.
Latest quarter: 2025/Q3. Revenue grew to 3,358,242,000 (+10.78% YoY), but profitability deteriorated: net income fell to 907,276,000 (-18.05% YoY) and EPS dropped to 0.04 (-20.00% YoY). Gross margin declined to 52.2 (down ~5.04% YoY). Net: top-line growth is intact, but margin/earnings trends are moving the wrong direction, which is typically not ideal for an impatient buy-the-dip trade.
Recent trend: price targets were cut across multiple firms, reflecting tempered near-term expectations. Barclays lowered PT to $12 (Equal Weight) citing decelerating transaction service revenue growth; Jefferies kept Buy with a slightly trimmed PT ($13) noting revenue beat but earnings miss due to taxes; Morgan Stanley kept Overweight but cut PT to $14, pointing to Q4 order volume guidance below expectations (seasonal/quality cleanup) yet seeing 2026 momentum intact. Wall Street pros: still generally constructive on the medium-term story with targets well above spot. Cons: near-term growth deceleration and guidance/quality adjustments are creating uncertainty, and the market is trading it like a near-term risk asset.
Intellectia Proprietary Trading Signals
Influential/political trading: Hedge funds neutral; insiders neutral; no recent Congress trading data in the last 90 days.
